The global nutraceutical ingredients market size was accounted for USD 88.65 billion in 2024, grew to USD 95.73 billion in 2025 and is predicted to surpass around USD 191.04 billion by 2034, representing a healthy CAGR of 7.98% between 2025 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Nutraceutical Ingredients Market, by Product Type, 2025-2034
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast (2022-2034)
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast (2022-2034)
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast (2022-2034)
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast (2022-2034)
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast (2022-2034)
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast (2022-2034)
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast (2022-2034)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2022-2034)
8.1. Nutraceutical Ingredients Market, by Application, 2025-2034
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast (2022-2034)
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast (2022-2034)
9.1. Nutraceutical Ingredients Market, by Health Benefits, 2025-2034
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast (2022-2034)
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast (2022-2034)
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast (2022-2034)
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast (2022-2034)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2022-2034)
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast (2022-2034)
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast (2022-2034)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2022-2034)
10.1. Nutraceutical Ingredients Market, by Form, 2025-2034
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast (2022-2034)
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast (2022-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2022-2034)
11.1.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.1.4. Market Revenue and Forecast, by Form (2022-2034)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.1.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2022-2034)
11.1.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.6.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.1.6.4. Market Revenue and Forecast, by Form (2022-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2022-2034)
11.2.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.2.4. Market Revenue and Forecast, by Form (2022-2034)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.2.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2022-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.6.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.2.6.4. Market Revenue and Forecast, by Form (2022-2034)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2022-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.7.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.2.7.4. Market Revenue and Forecast, by Form (2022-2034)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2022-2034)
11.2.8.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.8.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.2.8.4. Market Revenue and Forecast, by Form (2022-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2022-2034)
11.3.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.3.4. Market Revenue and Forecast, by Form (2022-2034)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.3.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2022-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.6.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.3.6.4. Market Revenue and Forecast, by Form (2022-2034)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2022-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.7.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.3.7.4. Market Revenue and Forecast, by Form (2022-2034)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2022-2034)
11.3.8.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.8.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.3.8.4. Market Revenue and Forecast, by Form (2022-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2022-2034)
11.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.4.4. Market Revenue and Forecast, by Form (2022-2034)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.4.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2022-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.6.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.4.6.4. Market Revenue and Forecast, by Form (2022-2034)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2022-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.7.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.4.7.4. Market Revenue and Forecast, by Form (2022-2034)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2022-2034)
11.4.8.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.8.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.4.8.4. Market Revenue and Forecast, by Form (2022-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2022-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.5.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.5.5.4. Market Revenue and Forecast, by Form (2022-2034)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2022-2034)
11.5.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.6.3. Market Revenue and Forecast, by Health Benefits (2022-2034)
11.5.6.4. Market Revenue and Forecast, by Form (2022-2034)
12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample